The document discusses the erythrocyte sedimentation rate (ESR), a common medical test used to detect inflammation. It describes how ESR is measured by allowing anticoagulated blood to stand vertically and measuring the rate at which red blood cells sediment. Normal ESR rates vary by age and sex. Factors like plasma proteins, number of red blood cells, temperature, and anticoagulants can influence ESR. The document also outlines different methods for measuring ESR, including the Wintrobe and Westergren methods, and clinical situations where ESR may be evaluated.
I have listed out the LE cells structure and Microscopical examinaton of LE CELLS, Difference between tart cells and le cells, clinical symptoms and diagnostic procedure.
Erythrocyte Sedimentation Rate (ESR), a lecture for medical lab technicians at Baquba Technical Institute, Middle Technical University. All theoretical and practical notes about the test.
I have listed out the LE cells structure and Microscopical examinaton of LE CELLS, Difference between tart cells and le cells, clinical symptoms and diagnostic procedure.
Erythrocyte Sedimentation Rate (ESR), a lecture for medical lab technicians at Baquba Technical Institute, Middle Technical University. All theoretical and practical notes about the test.
An immature red blood cell without a nucleus, having a granular or reticulated appearance when suitably stained.
Reticulocytes are the immature RBC that contain nucleus.
They are originally seen at the site of their formation i.e. bone marrow. They take 2-3 (lays for maturation only about 1-2% of circulating RBCs are Reticulocytes.
An immature red blood cell without a nucleus, having a granular or reticulated appearance when suitably stained.
Reticulocytes are the immature RBC that contain nucleus.
They are originally seen at the site of their formation i.e. bone marrow. They take 2-3 (lays for maturation only about 1-2% of circulating RBCs are Reticulocytes.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
2. ERYTHROCYTE SEDIMENTATION
RATE
COMMONLY USED NON SPECIFIC TEST IN ROUTINE
CLINICAL PRACTICE
OTHER HIGH SENSITIVITY INFLAMMATORY MARKERS
( EG. C-REACTIVE PROTEIN) ARE PRESENTLY USED TO
DETECT OR MONITOR DISEASE ( EG.
CARDIOVASCULAR DISEASE AND METABOLIC
SYNDROME )
06-Nov-17
G.KALAIVANI
2
3. ERYTHROCYTE SEDIMENTAION RATE
PRINCIPLE
WHEN ANTICOAGULATED BLOOD IS PLACED IN A
VERTICAL TUBE AND IS ALLOWED TO STAND,RBCS
SETTLE TOWARDS THE BOTTOM OF THE TUBE
SPEED OF SEDIMENTATION OF RED CELLS IN
PLASMA OVER A PERIOD OF 1 HOUR IS
MEASURED BY THE LENGTH OF THE SEDIMENT
RBC COLUMN AND IS EXPRESSED IN MILLIMETERS
06-Nov-17
G.KALAIVANI
3
4. ERYTHROCYTE SEDIMENTAION
RATE
RBCS HAVE NET NEGATIVE CHARGE ON THEIR
SURFACE AND TEND TO REPEL EACH OTHER .THE
REPULSIVE FORCES ARE PARTIALLY OR TOTALLY
COUNTERACTED IF THERE IS AN INCREASE IN THE
POSITIVELY CHARGED PLASMA PROTEINS
THIS PROCESS IS CALLED “SEDIMENTATION”
OVER A PERIOD OF 1 HOUR IS MEASURED BY THE
LENGTH OF THE SEDIMENT RBC COLUMN
EXPRESSED IN MILLIMETERS
06-Nov-17
G.KALAIVANI
4
5. STAGES OF ESR
SEDIMENTATION OCCUR IN 3 STAGES
STAGE OF AGGREGATION (FORMATION OF A
NUMBER OF THINGS INTO A CLUSTER)/ROULEAUX
FORMATION :
IN THE INITIAL 10 MINUTES, THERE IS LITTLE
SEDIMENTATION AS ROULEAUX FORM AND THE
SIZE OF THE ROULEAUX FORMED INFLUENCED THE
SPEED OF SEDIMENTAION
STAGE OF SETTLING: FOR 40 MINUTES ,SETTLING
OCCURS AT A CONSTANT RATE
STAGE OF PACKING: PACKING OF RBCs OCCURS IN
THE FINAL 10 MINUTES
06-Nov-17
G.KALAIVANI
5
12. WINTROBE ESR - PROCEDURE
WHOLE BLOOD COLLECTED IN WINTROBE,S”
BALANCED OXALATE “ OR EDTA
USING THE SPECIAL PIPETTE,TRANSFER WELL
MIXED BLOOD FROM THE SAMPLE BOTTLE
FILL THE SPECIAL WINTROBE TUBE TO THE 0.0
MARK NEAR THE TOP OF THE TUBE
(THE TUBE CONTAIN ABOUT 1ml OF BLOOD)
06-Nov-17
G.KALAIVANI
12
13. WINTROBE ESR – PROCEDURE
PLACE IT VERTICALLY IN THE STAND & NOTE THE
TIME
EXACTLY AFTER 1 HOUR,EXAMINE THE TUBE
NOTE THE READING OF THE LEVEL OF THE TOP
OF THE RBC COLUMN
THIS READING IN mm CORRESPONDS TO THE ESR
06-Nov-17
G.KALAIVANI
13
14. ADVANTAGES
SIMPLE
REQUIRES SMALL AMOUNT OF BLOOD
SAME TUBE CAN BE USED FOR BOTH ESR AND
PCV
BUFFY COAT SMEAR IS USEFUL IN CASES OF
LEUKOPENIA
06-Nov-17
G.KALAIVANI
14
15. DISADVANTAGE
• ESR VALUE HIGHER THAN PCV WHICH CAN NOT
BE OBTAINED BY THIS METHOD
06-Nov-17
G.KALAIVANI
15
16. ALTERNATIVELY METHODS
CAPILLARY METHOD (MICRO ESR METHOD): REQUIRES
ONLY O.2 ml OF BLOOD
USEFUL IN PEDIATRIC PATIENTS
ZETA SEDIMENTATION RATE : SPECIAL DEVICE ZETAFUGE
IS USED
AUTOMATED ESR : RESULTS ARE OBTAINED WITHIN 30
MINUTES AND ARE COMPARABLE WITH WESTERGREN 1
HOUR READING
ESR STAT PLUS : CENTRIFUGATION –BASED METHOD
06-Nov-17
G.KALAIVANI
16
21. WESTERGREN ESR – PROCEDURE
A WESTERGREN PIPETTE IS FILLED UP TO THE “ZERO”
MARK
PLACED VERTICALLY IN THE WESTERGREN RACK AT
ROOM TEMPERATURE
AFTER 60 MINUTES,THE DISTANCE BETWEEN THE TOP
OF THE RED CELL COLUMN
“ZERO “ MARK IS NOTED IN MILLIMETERRS AS ESR
READINGS
RESULT: ESR IS EXPRESSED AS mm AT THE END OF ONE
HOUR
06-Nov-17
G.KALAIVANI
21
23. MODIFIED WESTERGREN
METHOD
• USES BLOOD WITH ANTICOAGULATED WITH EDTA
RATHER THAN WITH CITRATE
• PRODUCES THE SAME RESULTS
• ADVANTAGES – MORE CONVENIENT
• ESR CAN BE PERFORMED FROM THE SAME TUBE OF
BLOOD COLLECTED FOR OTHER HAEMATOLOGIC STUDIES
• ESR CAN BE TWO MILLIMETERS OF WELL –MIXED EDTA –
BLOOD IS DILUTED WITH 0.5 ml OF 3.8%SODIUM
CITRATE OR WITH 0.5 ml of 0.85% SODIUM CHLORIDE
06-Nov-17
G.KALAIVANI
23
24. Revised normal range for ESR
AGE MEN WOMEN
Below 50 years 15mm/ hour 20mm/hour
Above 50 years 20mm/hour 30mm/hour
Above age 85
years
30mm/hour 42mm/hour
06-Nov-17
G.KALAIVANI
24
25. SIGNIFICANCE OF ESR
• PROGNOSTIC TEST RATHER THAN A DIAGNOSTIC
TEST
• ESR IS ONE OF THE JONES MINOR CRITERIA FOR
THE DIAGNOSIS OF RHEUMATIC FEVER
06-Nov-17
G.KALAIVANI
25
28. APPLICATION OF ESR & CLINICAL
SIGNIFICANCE
• SICKLE CELL DISEASE: LOW ESR IN THE ABSENCE OF
PAINFUL CRISIS AND MODERATELY RAISED 1 WEEK
INTO THE CRISIS
• OSTEOMYELITIS: ELEVATED AND USEFUL IN FOLLOW
UP
• STROKE: ESR≥28MM/HOUR IS POOR DIAGNOSTIC
FEATURE
06-Nov-17
G.KALAIVANI
28
29. PHYSIOLOGICAL FACTORS INFLUENCING THE
RATE OF SEDIMENTAION
1.PLASMA FACTORS – AN ACCELERATED ESR IS FAVOURED BY
ELEVATED LEVELS GLOBULINS ,FIBROGEN AND CHOLESTEROL
2.NUMBER OF CELLS – INCREASES IN ANEMIA
DECREASES IN POLYCYTHEMIA
3.AGE - ESR IS LOW – CHILDHOOD
ELDER PEOPLE SLIGHTLY INCREASED
4.GENDER – ESR IS SLIGHTLY HIGHER IN WOMEN THAN MEN
DUE TO THE FACT THAT WOMEN TEND TO HAVE
SLIGHTLY LOWER PCV VALUES
5.PREGNANCY – ESR BEGINS TO INCREASE IN THIRD MONTH OF
PREGNANCY
RETURNS TO NORMAL 3-4 WEEKS AFTER DELIVERY
06-Nov-17
G.KALAIVANI
29
30. APPLICATION OF ESR &
CLINICAL SIGNIFICANCE
• CANCER OF PROSTATE: ESR ≥ 37mm/hr IS ASSOCIATED
WITH HIGHER INCIDENCE OF DISEASE ( PROGRESSION AND
DEATH)
• PREGNANCY : ESR MODERATELY INCREASES BEGINNING AT
THE 10TH -12TH WEEK AND RETURN TO NORMAL ABOUT 1
MONTH POSTPARTUM
06-Nov-17
G.KALAIVANI
30
31. LABORATORYFACTORSINFLUENCINGTHE
ESR
1.TEMPERATURE – SEDIMENTATION RATE IS INCREASED
AT HIGHER TEMPERATURE
NORMALLY PEOPLE HAVE A SLIGHTLY HIGHER ESR
ESR IS ALWAYS DONE AT ROOM TEMPERATURE
CARE SHOULD BE TAKEN THAT THE APPARATUS IS
NOT EXPOSED TO THE DIRECT RAYS OF THE SUN
COMING THROUGH A WINDOW OR TO SOME OTHER
SOURCE OF HEAT
06-Nov-17
G.KALAIVANI
31
32. 2.TIME
PROGRESSIVE
BLOOD HAS BEEN STANDING FOR MORE
THAN 4 HOURS
ESR WILL DECREASE CONSIDERABLY
06-Nov-17
G.KALAIVANI
32
34. 4.THE LENGTH OF THE TUBE
ESR IS GREATER WITH LONGER TUBE
5.INCINATION OF THE TUBE
IF THE TUBE IS PLACED IN A RACK IN WHICH IT IS SLANTED
OR DEVIATED FROM THE VERTICAL
THE RATE OF SEDIMENTATION WILL BE INCREASED
ENSURE THAT THE TUBES ARE HELD EXACTLY VERTICALLY
06-Nov-17
G.KALAIVANI
34
35. 6.MOVEMENT OR AGITATION OF THE TUBE
TUBE SHOULD BE HELD ON A TABLE WHICH IS
NOT BEING BUMPED OR VIBRATED
SUCH EQUIPMENT AS CENTRIFUGES OR
SHAKERS AS AGITATION OF THE BLOOD DURING
THE PERIOD OF THE TEST
06-Nov-17
G.KALAIVANI
35
37. LUPUS ERYTHEMATOUS CELL
TEST
• IN AUTOIMMUNE DISEASES (E.G.SLE, RHEUMATOID
ARTHRITIS)
• VARIETY OF ANTIBODIES ARE FOUND
• ONE OF THEM IS AN ANTINUCLEAR ANTIBODY (ANA)
WHICH CANNOT PENETRATE INTACT CELLS
• ANAS CAN REACT WITH NUCLEI OF DAMAGED CELLS &
CONVERT NUCLEAR CHROMATIN INTO HOMOGENOUS
MATERIAL
06-Nov-17
G.KALAIVANI
37
38. LUPUS ERYTHEMATOUS CELL
TEST
• IN VIVO, ANAS ACT ON THE NUCLEI OF DAMAGED CELLS
AND DENATURES IT INTO HOMOGENOUS MATERIAL
• THIS NUCLEAR MATERIAL IS PHAGOCYTOSED IN THE
PRESENCE OF COMPLEMENTARY BY PHAGOCYTIC
LEUKOCYTE (NEUTROPHIL OR MACROPHAGES)
• LE CELL IS ANY PHAGOCYTIC LEUKOCYTE TISSUE THEY
ARE KNOWN AS LE BODIES OR HEMATOXYLIN BODIES .
06-Nov-17
G.KALAIVANI
38
39. LUPUS ERYTHEMATOUS CELL
TEST
• Tart cell : LE cell has to be differentiated from a
tart cell
• It is a monocyte/neutrophil containing a
phagocytosed nucleus of another cell
• The nuclear material is not homogeneous and it
retains its chromatin pattern
• It may be found in healthy individuals
06-Nov-17
G.KALAIVANI
39
40. PREVIOUS YEAR QUESTIONS
ESR (5 MARKS) APRIL 2017 ,FEB/MARCH 2011
FACTORS AFFECTING E.S.R (5 MARKS) FEB/MARCH 2012
E.S.R ESTIMATION BY WINTROBE’S METHOD (5 MARKS) FEB
2010
DEFINE ESR.DISCUSS VARIOUS METHODS OF ESR
ESTIMATION AND FACTORS INFLUENCING ESR .(AUGUST
2010 )
ESR – WHAT IS THE NAME OF THE INSTRUMENTS AND
ANTICOAGULANTS USED IN ESTIMATION OF E.S.R AND ITS
NORMAL VALUES IN MALES AND FEMALES? (3 MARKS)
AUG/SEP 2011
06-Nov-17
G.KALAIVANI
40
41. PREVIOUS YEAR QUESTIONS
NAME THE ANTICOAGULANT USED IN ESR
AND ITS CONCENTRATION?(3 MARKS) SEP
2012
ESTIMATION OF ESR (5 MARKS)MARCH
2013
06-Nov-17
G.KALAIVANI
41